Screening is vital
Screening enables early identification and removal of pre-cancerous lesions, dramatically reducing the incidence and mortality of cervical cancer worldwide.
Over 99% of cases of cervical cancer world-wide are caused by a virus called the human papillomavirus (HPV).
The most commonly used test to detect cervical cancer is the 'Pap smear' - but this method can miss instances of cervical cancer in women. This is why additional testing for HPV is vital for women.
Of the more than 100 different types of HPV, 14 of them are known as high-risk for the development of cervical cancer and its precursor lesions.
HPV types 16 and 18 have been identified as the highest risk genotypes. This is why regular testing for HPV 16 and 18, as well as the 12 other high-risk HPV types, is essential for women as it can detect the presence of these high risk genotypes so that preventative measures can be started without delay.